Coming back: autophagy in cachexia

Purpose of review Cachexia is a complex syndrome characterized by body weight loss, tissue wasting, systemic inflammation, metabolic abnormalities, and altered nutritional status. One of the most prominent features of cachexia is the loss of muscle mass, mainly because of increased protein degradation rates. This review is aimed at discussing the involvement of autophagy in the pathogenesis of muscle wasting in cachexia. Recent findings Modulations of muscle mass in the adult reflect an imbalance between protein synthesis and degradation rates. Muscle depletion in cachexia is associated with increased protein breakdown, mainly involving the pathways dependent on ubiquitin–proteasome and autophagy–lysosomes. This latter, in particular, was considered not relevant for a long time. Just in the last years, autophagy was shown to contribute to the pathogenesis of muscle wasting not only in myopathies because of intrinsic muscle defects, but also in muscle depletion associated with conditions such as sepsis, chronic obstructive pulmonary disease, glucocorticoid treatment, cancer cachexia, and aging. Summary The present review highlights that both excess and defective autophagy are relevant to the onset of muscle depletion, and draws some considerations about possible therapeutic intervention aimed at modulating autophagy in order to improve muscle trophism. Video abstract http://links.lww.com/COCN/A5.

[1]  N. Tardif,et al.  Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients. , 2013, The American journal of clinical nutrition.

[2]  L. Larsson,et al.  The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass , 2013, The Journal of cell biology.

[3]  M. Sandri Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome☆☆☆ , 2013, The international journal of biochemistry & cell biology.

[4]  A. Schols,et al.  Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. , 2013, The international journal of biochemistry & cell biology.

[5]  B. Jasmin,et al.  AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy. , 2013, Trends in molecular medicine.

[6]  Stefano Piccolo,et al.  BMP signaling controls muscle mass , 2013, Nature Genetics.

[7]  A. Goldberg,et al.  SIRT1 Protein, by Blocking the Activities of Transcription Factors FoxO1 and FoxO3, Inhibits Muscle Atrophy and Promotes Muscle Growth* , 2013, The Journal of Biological Chemistry.

[8]  D. Marks,et al.  Cancer‐ and endotoxin‐induced cachexia require intact glucocorticoid signaling in skeletal muscle , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Dingemans,et al.  Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. , 2013, The American journal of clinical nutrition.

[10]  M. Polkey,et al.  MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD , 2013, COPD.

[11]  Y. Min,et al.  Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans , 2013, PloS one.

[12]  R. Tompkins,et al.  Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate. , 2013, American journal of physiology. Endocrinology and metabolism.

[13]  M. Sandri,et al.  Role of autophagy in COPD skeletal muscle dysfunction. , 2013, Journal of applied physiology.

[14]  E. Blough,et al.  Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse , 2013, International journal of oncology.

[15]  P. Costelli,et al.  Autophagic degradation contributes to muscle wasting in cancer cachexia. , 2013, The American journal of pathology.

[16]  J. Woodgett,et al.  GSK-3α is a central regulator of age-related pathologies in mice. , 2013, The Journal of clinical investigation.

[17]  F. López‐Soriano,et al.  Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? , 2013, Biochimica et biophysica acta.

[18]  D. Klionsky,et al.  SnapShot: Selective Autophagy , 2013, Cell.

[19]  M. Sandri,et al.  Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.

[20]  Wen Dui,et al.  MST1, a key player, in enhancing fast skeletal muscle atrophy , 2013, BMC Biology.

[21]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[22]  P. Costelli,et al.  Ca(2+)-dependent proteolysis in muscle wasting. , 2005, The international journal of biochemistry & cell biology.